Is cronos a good project to invest in at current price

Cronos Group (CRON) does not appear to be a good investment at its current price for several reasons:

1. Financial Performance: Despite a notable 46% year-over-year increase in net revenue, Cronos reported a negative net margin of 56.43%, indicating that the company is not profitable as of the latest earnings release.
2. Strategic Positioning: While Cronos has a strong position in the Canadian cannabis market and has introduced new product innovations, the company's substantial cash reserve and low multiple suggest that it is not yet ready for significant growth.
3. Market Conditions: The cannabis industry is highly regulated and competitive, with multiple licensed producers operating in Canada. Cronos faces challenges in scaling overhead expenses and achieving profitability.
4. Institutional Confidence: Intact Investment Management Inc. reduced its holdings in Cronos by 67.1%, indicating a lack of confidence from a large investor.
5. Stock Volatility: Cronos' stock is highly volatile, with a beta of 1, indicating that it is as volatile as the S&P 500.
6. Valuation: Cronos has an enterprise value to next twelve months (EV/NTM) sales ratio of less than 1x, which is relatively low compared to its peers and suggests that the stock may be undervalued.

In conclusion, while Cronos has potential for growth, the company's current financial performance, market conditions, and valuation suggest that it is not a good investment at its current price. Investors should exercise caution and consider these factors before making an investment decision.